Laboratory Reagents Outlook: Clot-Free Sheep Blood for Blood Agar & Bacterial Isolation
公開 2026/04/02 17:18
最終更新
-
Global Leading Market Research Publisher QYResearch announces the release of its latest report "Sterile Defidrinated Sheep Blood - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Sterile Defidrinated Sheep Blood market, including market size, share, demand, industry development status, and forecasts for the next few years.
For microbiology laboratories, clinical diagnostic facilities, and biomedical research institutions, preparing culture media that supports the growth of fastidious bacteria requires high-quality blood products free from anticoagulants and preservatives. The global Sterile Defibrinated Sheep Blood market addresses this need through industrial-grade blood collected from healthy sheep in a closed system and processed to remove fibrin. Free of anticoagulants and preservatives, this blood provides essential nutrients (such as Factor X and Factor V) for bacterial and cell culture, making it ideal for blood agar plate preparation, bacterial isolation and culture, and biomedical research.
The global market for Sterile Defidrinated Sheep Blood was estimated to be worth US$ 120 million in 2025 and is projected to reach US$ 190 million, growing at a CAGR of 6.9% from 2026 to 2032. In 2024, global production reached 355.66 kiloliters, with an average selling price of US$ 335.3 per liter. This steady growth reflects consistent demand from clinical microbiology and pharmaceutical quality control laboratories.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6097353/sterile-defidrinated-sheep-blood
Essential Blood Product for Microbiology Culture
Sterile defibrinated sheep blood is an industrial product obtained by collecting blood from healthy sheep in a closed system and then processing it on a glass bead shaker to remove the fibrin. It is free of anticoagulants and preservatives. It is primarily used as a culture medium additive to provide nutrients (such as Factor X and Factor V) for bacteria and cells, and is suitable for blood agar plate preparation, bacterial isolation and culture, and biomedical research.
Sheep blood is preferred for many microbiology applications because it provides optimal growth factors for fastidious organisms such as Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria species. The defibrination process removes fibrin while preserving red blood cells and serum components. Unlike anticoagulant-treated blood, defibrinated blood does not contain chemicals that may inhibit bacterial growth.
Industry Segmentation: Packaging Sizes & Applications
The Sterile Defibrinated Sheep Blood market is segmented by container volume and end-use setting:
50ml: Small-volume bottles for research laboratories and teaching institutions with limited throughput. A university microbiology lab recently standardized on 50ml sheep blood for student laboratory exercises.
100ml: Common size for clinical diagnostic laboratories performing routine culture and sensitivity testing.
250ml: Mid-volume size for hospital microbiology departments and regional reference laboratories.
500ml: Large-volume bottles for high-throughput clinical laboratories, pharmaceutical quality control, and industrial microbiology.
Others: Custom volumes for specialized applications.
Application Segments
Biomedicine: Clinical diagnostic microbiology, hospital laboratories, and reference laboratories use sterile defibrinated sheep blood for blood agar base preparation and pathogen culture from patient specimens.
Research: Pharmaceutical R&D, academic research, and veterinary diagnostic laboratories utilize sheep blood for bacterial culture, antibiotic susceptibility testing, and vaccine development.
Technology Developments & Quality Standards
Over the past six months, several developments have shaped the market. Improved closed-system collection methods have enhanced sterility assurance and reduced contamination rates. Extended shelf-life formulations (up to 2 years with proper storage) have reduced waste for lower-volume laboratories. Enhanced quality control documentation (certificates of analysis for each lot) supports regulatory compliance for pharmaceutical and clinical customers.
The trend toward laboratory consolidation and centralized microbiology services has increased demand for larger packaging sizes and consistent supply. Regulatory requirements for culture media quality control (CLSI, ISO standards) drive demand for validated, documented blood products. Animal welfare and sourcing transparency have become considerations for some institutional purchasers.
Regional Market Dynamics
North America leads the sterile defibrinated sheep blood market, driven by high clinical microbiology testing volumes and strong pharmaceutical quality control requirements. The United States dominates with significant hospital and reference laboratory demand.
Europe follows closely, with strong microbiology infrastructure in Germany, France, and the UK, and regulatory requirements for culture media quality. Asia-Pacific is the fastest-growing region, with expanding clinical laboratory networks, increasing infectious disease testing, and growing pharmaceutical manufacturing in China, India, and Southeast Asia.
Competitive Landscape
Key players include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Trafalgar Scientific, HemoStat Laboratories, Dutscher, Serana Europe, Innovative Research Inc, Colorado Serum, SSI Diagnostica, SR Group, Szabo-Scandic, Rockland Immunochemicals, LABone Scientific, Guangzhou Ruite Biotechnology, Obio Technology (Shanghai), Beijing Solarbio Science & Technology, Nanjing SenBeiJia Biological Technology, Changde BKMAM Biotechnology, and Beijing Baiao Leibo Technology.
Market Segmentation
The Sterile Defidrinated Sheep Blood market is segmented as below:
By Company
Thermo Fisher Scientific
TCS Biosciences
BioMérieux
E & O Laboratories Ltd
Southern Biological
Trafalgar Scientific
HemoStat Laboratories
Dutscher
Serana Europe
Innovative Research Inc
Colorado Serum
SSI Diagnostica
SR Group
Szabo-Scandic
Rockland Immunochemicals, Inc.
LABone Scientific Co.Ltd.
Guangzhou Ruite Biotechnology Co., Ltd.
Obio Technology (Shanghai) Corp., Ltd.
Beijing Solarbio Science & Technology Co.,Ltd.
Nanjing SenBeiJia Biological Technology Co., Ltd.
Changde BKMAM Biotechnology Co. Ltd.
Beijing Baiao Leibo Technology Co., Ltd.
Segment by Volume
50ml
100ml
250ml
500ml
Others
Segment by Application
Biomedicine
Research
Exclusive Industry Outlook
Looking ahead, the convergence of sterile defibrinated sheep blood supply with automation in clinical microbiology and expanding diagnostic testing represents a steady growth opportunity. The trend toward laboratory consolidation will favor suppliers with robust quality systems and reliable supply chains. Development of synthetic or animal-free alternatives for certain applications may emerge but is unlikely to fully replace sheep blood for specific fastidious organisms. Additionally, the expansion of infectious disease surveillance programs and antimicrobial resistance monitoring will create new demand. The ability to offer sterile defibrinated sheep blood that combines consistent quality, sterility, and supply reliability—supported by comprehensive documentation and global distribution—will define competitive differentiation.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
For microbiology laboratories, clinical diagnostic facilities, and biomedical research institutions, preparing culture media that supports the growth of fastidious bacteria requires high-quality blood products free from anticoagulants and preservatives. The global Sterile Defibrinated Sheep Blood market addresses this need through industrial-grade blood collected from healthy sheep in a closed system and processed to remove fibrin. Free of anticoagulants and preservatives, this blood provides essential nutrients (such as Factor X and Factor V) for bacterial and cell culture, making it ideal for blood agar plate preparation, bacterial isolation and culture, and biomedical research.
The global market for Sterile Defidrinated Sheep Blood was estimated to be worth US$ 120 million in 2025 and is projected to reach US$ 190 million, growing at a CAGR of 6.9% from 2026 to 2032. In 2024, global production reached 355.66 kiloliters, with an average selling price of US$ 335.3 per liter. This steady growth reflects consistent demand from clinical microbiology and pharmaceutical quality control laboratories.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6097353/sterile-defidrinated-sheep-blood
Essential Blood Product for Microbiology Culture
Sterile defibrinated sheep blood is an industrial product obtained by collecting blood from healthy sheep in a closed system and then processing it on a glass bead shaker to remove the fibrin. It is free of anticoagulants and preservatives. It is primarily used as a culture medium additive to provide nutrients (such as Factor X and Factor V) for bacteria and cells, and is suitable for blood agar plate preparation, bacterial isolation and culture, and biomedical research.
Sheep blood is preferred for many microbiology applications because it provides optimal growth factors for fastidious organisms such as Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria species. The defibrination process removes fibrin while preserving red blood cells and serum components. Unlike anticoagulant-treated blood, defibrinated blood does not contain chemicals that may inhibit bacterial growth.
Industry Segmentation: Packaging Sizes & Applications
The Sterile Defibrinated Sheep Blood market is segmented by container volume and end-use setting:
50ml: Small-volume bottles for research laboratories and teaching institutions with limited throughput. A university microbiology lab recently standardized on 50ml sheep blood for student laboratory exercises.
100ml: Common size for clinical diagnostic laboratories performing routine culture and sensitivity testing.
250ml: Mid-volume size for hospital microbiology departments and regional reference laboratories.
500ml: Large-volume bottles for high-throughput clinical laboratories, pharmaceutical quality control, and industrial microbiology.
Others: Custom volumes for specialized applications.
Application Segments
Biomedicine: Clinical diagnostic microbiology, hospital laboratories, and reference laboratories use sterile defibrinated sheep blood for blood agar base preparation and pathogen culture from patient specimens.
Research: Pharmaceutical R&D, academic research, and veterinary diagnostic laboratories utilize sheep blood for bacterial culture, antibiotic susceptibility testing, and vaccine development.
Technology Developments & Quality Standards
Over the past six months, several developments have shaped the market. Improved closed-system collection methods have enhanced sterility assurance and reduced contamination rates. Extended shelf-life formulations (up to 2 years with proper storage) have reduced waste for lower-volume laboratories. Enhanced quality control documentation (certificates of analysis for each lot) supports regulatory compliance for pharmaceutical and clinical customers.
The trend toward laboratory consolidation and centralized microbiology services has increased demand for larger packaging sizes and consistent supply. Regulatory requirements for culture media quality control (CLSI, ISO standards) drive demand for validated, documented blood products. Animal welfare and sourcing transparency have become considerations for some institutional purchasers.
Regional Market Dynamics
North America leads the sterile defibrinated sheep blood market, driven by high clinical microbiology testing volumes and strong pharmaceutical quality control requirements. The United States dominates with significant hospital and reference laboratory demand.
Europe follows closely, with strong microbiology infrastructure in Germany, France, and the UK, and regulatory requirements for culture media quality. Asia-Pacific is the fastest-growing region, with expanding clinical laboratory networks, increasing infectious disease testing, and growing pharmaceutical manufacturing in China, India, and Southeast Asia.
Competitive Landscape
Key players include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Trafalgar Scientific, HemoStat Laboratories, Dutscher, Serana Europe, Innovative Research Inc, Colorado Serum, SSI Diagnostica, SR Group, Szabo-Scandic, Rockland Immunochemicals, LABone Scientific, Guangzhou Ruite Biotechnology, Obio Technology (Shanghai), Beijing Solarbio Science & Technology, Nanjing SenBeiJia Biological Technology, Changde BKMAM Biotechnology, and Beijing Baiao Leibo Technology.
Market Segmentation
The Sterile Defidrinated Sheep Blood market is segmented as below:
By Company
Thermo Fisher Scientific
TCS Biosciences
BioMérieux
E & O Laboratories Ltd
Southern Biological
Trafalgar Scientific
HemoStat Laboratories
Dutscher
Serana Europe
Innovative Research Inc
Colorado Serum
SSI Diagnostica
SR Group
Szabo-Scandic
Rockland Immunochemicals, Inc.
LABone Scientific Co.Ltd.
Guangzhou Ruite Biotechnology Co., Ltd.
Obio Technology (Shanghai) Corp., Ltd.
Beijing Solarbio Science & Technology Co.,Ltd.
Nanjing SenBeiJia Biological Technology Co., Ltd.
Changde BKMAM Biotechnology Co. Ltd.
Beijing Baiao Leibo Technology Co., Ltd.
Segment by Volume
50ml
100ml
250ml
500ml
Others
Segment by Application
Biomedicine
Research
Exclusive Industry Outlook
Looking ahead, the convergence of sterile defibrinated sheep blood supply with automation in clinical microbiology and expanding diagnostic testing represents a steady growth opportunity. The trend toward laboratory consolidation will favor suppliers with robust quality systems and reliable supply chains. Development of synthetic or animal-free alternatives for certain applications may emerge but is unlikely to fully replace sheep blood for specific fastidious organisms. Additionally, the expansion of infectious disease surveillance programs and antimicrobial resistance monitoring will create new demand. The ability to offer sterile defibrinated sheep blood that combines consistent quality, sterility, and supply reliability—supported by comprehensive documentation and global distribution—will define competitive differentiation.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
最近の記事
タグ